Finally, Gorman pointed out that cancer survivors have become very frustrated with conversations about how to bring the best care models and goals to widespread use that begin with the question, How can it be paid for? “Personally, I prefer a dialogue that begins with the question, ‘What do patients and cancer survivors need?’ Then we move on to the questions of how can incentives be aligned to realize it.”
The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine "
4 Patients ."
Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary . Washington, DC: The National Academies Press,
Please select a format: